[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364091-105":59,"doc-detail-364091-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","atm-variants-and-breast-cancer-risk-in-north-macedonia-focus-on-the-regionally-enriched-pleu2492arg-variant","ATM Variants and Breast Cancer Risk in North Macedonia - Focus on the Regionally Enriched p.(Leu2492Arg) Variant","","Retrospective case–control analysis of 1,211 North Macedonian patients with breast cancer assessed germline ATM variants using a targeted hereditary cancer gene panel and compared results with 1,303 population-based controls analyzed by exome sequencing. Pathogenic ATM variants were found in 1.9% of cases versus 0.4% of controls (OR=5.02, p=0.0006). Six recurrent variants explained over 70% of detections, indicating regional enrichment. The p.(Leu2492Arg) variant showed higher detection in cases (1.9% vs 1.1%), with higher allele frequency than global databases.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/atm-variants-and-breast-cancer-risk-in-north-macedonia-focus-on-the-regionally-enriched-pleu2492arg-variant/364091/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/atm-variants-and-breast-cancer-risk-in-north-macedonia-focus-on-the-regionally-enriched-pleu2492arg-variant/364091.png","ImageObject",300,407,{"name":92,"@type":93},"anakgang17","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was ATM variant prevalence measured in breast cancer patients and controls?","Question",{"text":112,"@type":113},"ATM variants were analyzed in 1,211 North Macedonian breast cancer patients using a targeted hereditary cancer gene panel and compared with 1,303 population-based controls analyzed by clinical exome or whole-exome sequencing.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did the study find about the overall risk of breast cancer linked to pathogenic ATM variants?",{"text":117,"@type":113},"Pathogenic ATM variants were identified in 1.9% of cases and 0.4% of controls, corresponding to a significantly increased breast cancer risk (OR=5.02, p=0.0006).",{"name":119,"@type":110,"acceptedAnswer":120},"Why is the p.(Leu2492Arg) variant a key focus in this population?",{"text":121,"@type":113},"The p.(Leu2492Arg) missense variant was more frequently detected in cases than controls (1.9% vs 1.1%) and showed a higher allele frequency in this population than in global databases, suggesting population-specific enrichment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364091,1790200095,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Brief Report  \n524  \nBalkan Med J 2026;43:524-531  \nContent of this journal is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.  \nATM Variants and Breast Cancer Risk in North Macedonia: Focus on the Regionally Enriched p.(Leu2492Arg) Variant  \n Ivana Maleva Kostovska,  Sanja Kiprijanovska,  Predrag Noveski,  Marija Vujovikj,  Marija Terzic,  \n Dijana Plaseska-Karanfilska  \nResearch Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Macedonian Academy of Science and Arts, Skopje, North Macedonia  \nBackground: Germline pathogenic variants (PVs) in the ataxiatelangiectasia mutated (ATM) gene are established moderate-risk factors for breast cancer (BC), however, population-specific variant spectra and the clinical significance of many missense variants remain incompletely characterized.  \nAims: To evaluate the prevalence of ATM variants in a large cohort of patients with BC from North Macedonia and compare it with that in the general population, with a particular focus on the frequency of thep. (Leu2492Arg) variant and its distribution relative to global genomic datasets.  \nStudy Design: Retrospective case–control study.  \nMethods: ATM variants were analyzed in 1,211 patients with BC from North Macedonia using a targeted hereditary cancer gene panel. These findings were compared with those from 1,303 population-based controls analyzed by clinical exome or whole-exome sequencing.  \nResults: Pathogenic ATM variants were identified in 1.9% of BC cases and 0.4% of controls, indicating a significantly increased risk of BC [odds ratio (OR) = 5.02, p = 0.0006] . Most PVs were protein-truncating,  \nwith six recurrent variants accounting for over 70% of detections, suggesting regional enrichment. Carriers showed a significantly higher prevalence of human epidermal growth factor receptor 2-positive tumors (OR = 2.92, p = 0.0189) . Variants of uncertain significance were observed at comparable frequencies in cases and controls. The p. (Leu2492Arg) missense variant was more frequently detected in cases than in controls (1 .9% vs. 1. 1%; OR = 1.78, p = 0.086) and exhibited a markedly higher allele frequency in this population than in global databases.  \nConclusion: These findings confirm ATM as a clinically relevant BC susceptibility gene in North Macedonia and highlight the populationspecific enrichment of both PVs and the p. (Leu2492Arg) missense variant. The results emphasize the importance of using population-matched controls and regional genomic data for accurate risk assessment and variant interpretation.  \nINTRODUCTION  \nThe ataxia-telangiectasia mutated (ATM) gene, located on chromosome 11q22 .3, encodes a serine/threonine protein kinasethat is essential for maintaining genomic stability.1 Comprising 63 exons, ATM acts as a central regulator of cell cycle checkpoint signaling pathways. It is primarily activated in response to DNA doublestrand breaks, which represent one of the most cytotoxic forms of DNA damage.2 ATM activation is mediated by the MRE11–RAD50– NBS1 complex, after which it phosphorylates multiple downstream  \ntargets, including p53, BRCA1, CHEK2, and H2AX. This signaling cascade coordinates cell cycle arrest, DNA repair, or apoptosis, thereby preventing the accumulation and propagation of genomic damage.3 Pathogenic variants (PVs) in these genes impair DNA repair mechanisms and increase cancer susceptibility.4 Beyond its role in genome maintenance, ATM also influences several physiological processes, including neurological function, immune response, and aging. Biallelic PVs in ATM cause ataxia-telangiectasia (A–T), a rare autosomal recessive disorder characterized by progressive neurodegeneration, immunodeficiency, radiosensitivity, premature  \nCorresponding author: Dijana Plaseska-Karanfilska, Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Macedonian Academy of Science and Arts, Skopje, North Macedonia  \ne-mail: [dijan","cbCaiubT54grF8NH","https://ap.wps.com/l/cbCaiubT54grF8NH","pdf",155647,"English","# Background\n# Aims\n# Study Design\n# Methods\n# Results\n# Conclusion","[{\"question\":\"How was ATM variant prevalence measured in breast cancer patients and controls?\",\"answer\":\"ATM variants were analyzed in 1,211 North Macedonian breast cancer patients using a targeted hereditary cancer gene panel and compared with 1,303 population-based controls analyzed by clinical exome or whole-exome sequencing.\"},{\"question\":\"What did the study find about the overall risk of breast cancer linked to pathogenic ATM variants?\",\"answer\":\"Pathogenic ATM variants were identified in 1.9% of cases and 0.4% of controls, corresponding to a significantly increased breast cancer risk (OR=5.02, p=0.0006).\"},{\"question\":\"Why is the p.(Leu2492Arg) variant a key focus in this population?\",\"answer\":\"The p.(Leu2492Arg) missense variant was more frequently detected in cases than controls (1.9% vs 1.1%) and showed a higher allele frequency in this population than in global databases, suggesting population-specific enrichment.\"}]","ATM Variants and Breast Cancer Risk in North Macedonia - Focus on the Regionally Enriched p.(Leu2492Arg) Variant | PDF",1790155591,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6973677b4670640f42cdd1766e662302.webp",983,1280,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de1e72e9040f8d7a62007fada0b97a5d.webp",982,1278,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0372c06ec8e4b6019063ae4b32583d86.webp",981,1277,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a1bb59cc479ceee710e238ce64a5440.webp",980,1276]